checkAd
Halberd Aktie
0,019
 
USD
21:59:21 Nasdaq OTC
-17,45 %
-0,004 USD

JACKSON CENTER, PA / ACCESSWIRE / December 6, 2021 / Halberd Corporation (OTC PINK:HALB) completed verification tests on elimination of Tumor Necrosis Factor-alpha (TNF-alpha) from synthetic cerebral spinal fluid (CSF). These tests confirmed …

Wertpapier:

JACKSON CENTER, PA / ACCESSWIRE / November 22, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 85% of Tumor Necrosis Factor-alpha (TNF-α) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Through Halberd's …

Wertpapier:

Nachrichten

DatumTitel
08.11.21Halberd Files Additional Extracorporeal Patent Application: Treatment of Covid-19 By Exposure to Tuned Radio Frequency Waves
Accesswire | Analysen
01.11.21Halberd Successfully Eradicates IL-6, a Critical Factor in PTSD, CTE & Alzheimer’s Disease
Accesswire | Analysen
25.10.21Halberd Files Provisional Patent on Breakthrough Obesity Treatment
Accesswire | Analysen
20.10.21Halberd's PTSD/Alzheimer's R&D Reveals Link to Potential Obesity Cure
Accesswire | Analysen
12.10.21Halberd and GTX Corp. Sign Scientific Collaboration and Reseller Agreement
Accesswire | Analysen
07.10.21Halberd Corporation CEO Letter
Accesswire | Analysen
05.10.21Halberd's VITASHIELDMAX(TM) Immunity Support Product Available on Amazon
Accesswire | Analysen
22.09.21Halberd and heliosDX of RushNet Enter Scientific Collaboration Agreement
Accesswire | Analysen
13.09.21Halberd's Treatment Eradicates Primary Building Block of Alzheimer’s Disease
Accesswire | Analysen
08.09.21Halberd Corporation Appoints Anthony Mirabelli Vice-President, Mergers & Acquisitions
Accesswire | Analysen
30.08.21Halberd Corporation Alzheimer's Disease Treatment Tests Yield Outstanding Results
Accesswire | Analysen
25.08.21Halberd Receives Patent for Treatment of Cockayne Syndrome - May Provide Pathway to Slow Aging
Accesswire | Analysen
23.08.21Halberd Files Provisional Patent Application - Furthering Efforts on Alzheimer's Disease
Accesswire | Analysen
18.08.21Halberd Corp. VITA-SHIELD-MAX(TM) Available - Buy Now!
Accesswire | Analysen
16.08.21Halberd’s Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN
Accesswire | Analysen